Company Overview of Paradigm Ltd.
Paradigm Ltd. develops software-enabled solutions for the global oil and gas industry. It offers seismic processing and imaging, interpretation and modeling, reservoir characterization, reservoir engineering, and data management and interoperability solutions, as well as well planning, drilling engineering, and geosteering solutions. The company also provides reservoir characterization and subsalt services. Its solutions help natural resources companies in assisting their exploration and production decisions by providing deeper insight into the subsurface. The company serves upstream oil and gas exploration and production customers, including oil companies, super-major exploration and produc...
Two Memorial Plaza
Houston, TX 77024
Founded in 1987
Key Executives for Paradigm Ltd.
Founder and Non-Executive Chairman
Founder and Senior Partner
Compensation as of Fiscal Year 2014.
Paradigm Ltd. Key Developments
Compania Mexicana de Exploraciones SA de CV Selects Paradigm Software Solutions for Seismic Processing and Imaging, Subsurface Modeling and Reservoir Characterization for its New Seismic Data Processing Center
Oct 27 14
Paradigm revealed that Compania Mexicana de Exploraciones SA de CV has selected Paradigm software solutions for seismic processing and imaging, subsurface modeling and reservoir characterization for its new Seismic Data Processing Center. As COMESA's Strategic Partner, Paradigm said its software solutions will allow COMESA to address diverse geophysical and geologic (G&G) subsurface challenges in its clients' exploration programmes. The partnership also represents Paradigm's continued growth in Mexico and across Latin America.
Paradigm Releases High Definition Enabled G&G Software Suite
Oct 8 14
Paradigm announced the release of the latest extension of its Paradigm 14 solution suite. This version, Paradigm 14.1, enables broadband processing, High Definition (HD) imaging, quantitative interpretation, and advances toward high-definition earth modeling. The new HD modeling improves the accuracy of production forecasts with models that are more closely representative of actual subsurface conditions. Honoring both seismic data and geology allows users to better quantify uncertainty in their reservoir, resulting in lower-risk reservoir management decisions, and better production planning and forecasting. Building on the company's heritage as an advanced science leader, this release allows customers to further integrate Paradigm science with even more software platforms, with the release of a new Petrel plugin. Some of the most significant enhancements in this release are in the Paradigm SKUA-GOCAD(TM) modeling suite, including: Enhanced modeling for unconventional plays, including microseismic data analysis, patented stimulation path generation, and stimulated rock volume assessment; Structural uncertainty modeling, allowing geoscientists to assess the impact of fault and horizon positional uncertainty on reservoir volumes, fault seal capacity, and flow simulation results; Restructuring of SKUA's volumetric interpretation capability to fast track interpretation and interpretation validation in depositional space, as well as the introduction of a new fault likelihood attribute for semi-automatic fault interpretation. Other new features in Paradigm 14 include: Easy transfer of surveys and interpretation picks between Petrel and Paradigm Epos, using a Petrel plug-in; Stratimagic(R) seismic facies classification as the first plug-in to the new Paradigm Epic open and integrated platform, enabling personalized and flexible window organization; Prestack gather preconditioning, stacking and inversion in the SeisEarth(R) 3D Canvas in support of Quantitative Seismic Interpretation workflows.
FORMA Therapeutics and Paradigm Announce Molecular Profiling Collaboration for Drug Candidates
Aug 12 14
Paradigm and FORMA Therapeutics, Inc. announced a multi-year partnership to identify predictive response markers and measure pharmacodynamic activity for two of FORMA's advanced preclinical candidates. Working with Paradigm to assess the potential of molecular markers to predict clinical outcomes will help FORMA accelerate clinical decisions and optimize its new medicines for patients. Collaboration with Paradigm enables FORMA to efficiently match drugs with high quality molecular assays to realize a personalized approach to cancer drug development.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|